284. Il vero affare da 5 miliardi delle infusioni a domicilio

Mentre tutti inseguono l'intelligenza artificiale, McKesson e il fondo CD&R stanno per comprare Option Care Health, il gigante nascosto che porta le terapie endovenose direttamente a casa di 315.000 pazienti. Scopri perché il futuro della sanità si gioca fuori dagli ospedali. Premi 'play' e scoprilo in meno di 5 minuti!

---

FONTI:

· Fonte 1: https://www.ft.com/content/0bc54eaf-d545-4591-bb7c-ec3cbc1cb89a

· Fonte 2: https://www.bloomberg.com/news/articles/2026-10-05/option-care-jumps-on-report-mckesson-is-preparing-an-offer

· Fonte 3: https://sg.finance.yahoo.com/news/option-care-health-surges-22-204447450.html

· Fonte 4: https://www.sec.gov/Archives/edgar/data/1014739/000114036126013825/ny20062823x1_def14a.htm

· Fonte 5: https://es.marketscreener.com/noticias/option-care-health-redefine-la-terapia-de-infusi-n-en-estados-unidos-ce7d5ddcdf8cf126

· Fonte 6: https://www.kirkland.com/news/press-release/2026/02/kirkland-advises-kinderhook-on-11-billion-acquisition-of-enhabit

🎧Spotify ➡️: https://bit.ly/4e5t6sC

https://www.linkedin.com/in/francescozambelli

https://youtube.com/@francesco_zambelli

https://www.instagram.com/atglaneconomix

https://www.facebook.com/share/1CBxjueLvF/

https://atglanceconomix.carrd.co/

https://whatsapp.com/channel/0029Vb6ZcP69hXF50YnZKV06

https://t.me/AtGlanEconomix

https://www.tiktok.com/@atglanceconomix?_r=1&_t=ZN-91kwQLH2Jao